Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment to Provide Optimal Care for Each Patient

In this CME video activity, experts in systemic lupus erythematosus (SLE) give a detailed discussion on the autoimmune disease, providing guidance on recognizing the clinical features and confirming a diagnosis, as well as contemporary strategies to manage diverse disease manifestations. Hear what the experts are doing in their clinics.

Target Audience

This activity has been designed to meet the educational needs of internal medicine physicians, family and general medicine physicians, rheumatologists, dermatologists, nephrologists, OB/GYNs, and other clinicians involved in the management of patients with lupus.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify systemic lupus erythematosus (SLE) as a heterogeneous autoimmune disease with a wide range of clinical and serological manifestations that can affect any organ
  • Employ appropriate criteria to confirm a diagnosis of SLE, recognizing the clinical utility of available classification systems
  • Utilize evidence-based tools to monitor disease activity in individual SLE patients in daily clinical practice and guide treatment decisions
  • Describe current treatment options for SLE according to mechanism of action, efficacy, safety, and impact on patient symptoms/quality of life
  • Develop treatment plans for individual patients with SLE to control disease activity and prevent or minimize disease flares, drug toxicity, and organ damage
  • Effectively communicate and collaborate with SLE patients and other care providers to understand and address the needs of each patient and maximize treatment adherence, quality of life, and survival outcomes

Additional Information

The Penn State College of Medicine
Course summary
Available credit: 
  • 0.00 MOC
  • 1.50 AMA PRA Category 1 Credit
Course opens: 
Course expires: 

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Kenneth C. Kalunian, MD

Professor of Medicine
Division of Rheumatology, Allergy and Immunology
University of California, San Diego School of Medicine
La Jolla, California

Kenneth C. Kalunian, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Amgen Inc.; AstraZeneca/MedImmune/Viela Bio; Biogen; Bristol Myers Squibb; ChemoCentryx, Inc.; Equillium, Inc.; Genentech, Inc./F. Hoffmann-La Roche Ltd; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; Kyowa Kirin Co., Ltd; and Nektar Therapeutics.
Grant/Research Support from Corbus Pharmaceuticals Holdings, Inc.; Gilead; Idorsia Pharmaceuticals Ltd; Pfizer Inc.; Resolve Therapeutics; and Takeda Pharmaceuticals U.S.A., Inc.

Maureen A. McMahon, MD

Associate Professor of Rheumatology
UCLA David Geffen School of Medicine
Los Angeles, California

Maureen A. McMahon, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Aurinia Pharmaceuticals Inc.; Eli Lilly and Company; and Exagen Inc.
Speakers Bureau participant with GlaxoSmithKline.

Joan T. Merrill, MD
Director of Clinical Projects, Arthritis and Clinical Immunology Program
Oklahoma Medical Research Foundation
Chief Advisor, Clinical Development
Lupus Foundation of America
OMRF Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma

Joan T. Merrill, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc.; Amgen Inc.; Astellas Pharma Inc.; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene Corporation/Bristol-Myers Squibb; Eli Lilly and Company; EMD Serono, Inc.; Genentech, Inc./F. Hoffmann-La Roche Ltd; GlaxoSmithKline; UCB, Inc.; Janssen Pharmaceuticals, Inc.; Neovacs S.A.; Pfizer Inc.; RemeGen, Ltd.; and Servier Pharmaceuticals LLC/ILTOO Pharma.
Grant/Research Support from Celgene Corporation/Bristol-Myers Squibb; Exagen Inc.; GlaxoSmithKline; and Xencor.

Medical Director
Kathryn B. Charalambous, PhD

PVI, PeerView Institute for Medical Education

Kathryn B. Charalambous has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or [email protected]. Reference course # G6581-21-T.

Available Credit

  • 0.00 MOC
  • 1.50 AMA PRA Category 1 Credit
Please login or register to take this course.

This course is offered through Penn State College of Medicine. To take this course you will be redirected to Penn State College of Medicine's website. You must have an account with Penn State College of Medicine in order to complete this activity.  

Mocingbird continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!